The John William Pope Foundation has made a $1.3 million gift to UNC Lineberger Comprehensive Cancer Center to fund cancer research and treatment.
The findings shed more light on cancer development and metastasis.
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
With the dedication of Marsico Hall, UNC ushered in a new era of medical research, collaboration, and promise for the people of North Carolina and beyond.
Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.
The finding, from the lab of William Marzluff, PhD, provides insight into how genetic diseases, such as various cancers, develop in the body.
The large-scale, cross-sectional study was published in The New England Journal of Medicine. Dr. David Ransohoff of UNC is one of the study's co-authors.
The lab of Klaus Hahn, PhD, developed a new technique to help scientists map the interactions between the proteins at the heart of many diseases.
When we fight an infection -- any invader -- our bodies conjure inflammatory responses, immune responses. But inside some individual cells, a similar reaction happens. Beth Knight, PhD, found out what transpires inside such cells involved in a kind of brain cancer called medulloblastoma and what role a particularly important protein plays in cancer development. This is the second profile in a continuing series of features on UNC School of Medicine graduate students.
Researchers at the UNC Lineberger Comprehensive Cancer Center found that bladder cancer subtypes are genetically similar to breast cancer subtypes.
The new technique, developed by UNC researchers, would be cheaper and could allow doctors to visualize tumors without the use of radiation.
This research could reduce the need to continually monitor patients who respond well to stereotactic radiosurgery.
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.
The next chapter in the story of UNC Lineberger Comprehensive Cancer Center begins with a new director, Ned Sharpless, an oncologist with a story to tell.
The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient’s share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.
The award, which includes $5,000 in direct research support, recognizes years of service to the CALGB cooperative group by Dr. Muss, who has been a member for more than 30 years.
Screening to detect medical conditions has become standard practice for many diseases, but insufficient attention has been paid to the potential for harm, according to research by a team led by Russell Harris, MD, MPH, of the UNC School of Medicine, UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center.
Adriana S. Beltran, PhD, a research assistant professor in the UNC School of Medicine, found that the protein Engrailed 1 is overexpressed in basal-like carcinomas, and she designed a chain of amino acids to shut down the protein and kill basal-like tumors in the lab.
A Dare County, N.C., wife and mother of three keeps her spunky, positive spirit intact during treatment for thyroid cancer, buoying herself, her family and her medical team on the journey.
This milestone makes the Carolina Breast Cancer Study the largest-ever population-based study of breast cancer in North Carolina and one of the largest in the world.